The Expression of ERCC1, RRM1, and BRCA1 in Breast Cancer According to the Immunohistochemical Phenotypes

被引：32

作者：

Kim, Dokyung ^{[1
]}

Jung, Woohee ^{[1
]}

Koo, Ja Seung ^{[1
]}

机构：

[1] Yonsei Univ, Severance Hosp, Coll Med, Dept Pathol, Seoul 120752, South Korea

来源：

JOURNAL OF KOREAN MEDICAL SCIENCE | 2011年 / 26卷 / 03期

关键词：

Breast Neoplasms; ERCC1; RRM1; BRCA1; MESSENGER-RNA LEVELS; GENE-EXPRESSION; FLUOROURACIL CHEMOTHERAPY; PROGNOSTIC FACTORS; CISPLATIN; SURVIVAL; REPAIR; PROTEIN; OXALIPLATIN; MUTATIONS;

D O I：

10.3346/jkms.2011.26.3.352

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We studied the expression of BRCA1, ERCC1, and RRM1 which play an important role in DNA repair systems in breast cancer. Immunohistochemical staining for EGFR, BRCA1, ERCC1, and RRM1 were performed by using a tissue microarray made from 230 breast cancer patients. Patients were classified into luminal A, luminal B, HER-2, and triple negative breast cancer (TNBC) types according to ER, PR, and HER-2 expression. The expression of ERCC1, RRM1, and BRCA1 were correlated (P < 0.05). The expression level of ERCC1 was the lowest in TNBC type (P = 0.031), ERCC1 negativity was more prominent in TNBC and luminal B groups than luminal A and HER-2 groups (P = 0.013). Cases with EGFR overexpression showed high expression of RRM1 and BRCA1 (P = 0.046, and 0.004, respectively). In conclusion, the expression of ERCC1 is particularly lower in TNBCs than other types of breast cancers.

引用

页码：352 / 359

页数：8

共 50 条

[1] In Situ Protein Expression of RRM1, ERCC1, and BRCA1 in Metastatic Breast Cancer Patients Treated with Gemcitabine-Based Chemotherapy
Metro, G.
Zheng, Z.
Fabi, A.
Schell, M.
Antoniani, B.
Mottolese, M.
Monteiro, A. N.
Vici, P.
Rivera, S. Lara
Boulware, D.
Cognetti, F.
Bepler, G.
CANCER INVESTIGATION, 2010, 28 (02) : 172 - 180
[2] In situ protein expression of RRM1, ERCC1, and BRCA1 in metastatic breast cancer patients treated with gemcitabine-including chemotherapy
Metro, G.
Zheng, Z.
Fabi, A.
Mottolese, M.
Monteiro, A. N.
Vici, P.
Boulware, D.
Rivera, S. Lara
Cognetti, F.
Bepler, G.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[3] ERCC1 and RRM1 Expression in Resected NSCLC
Pavicevic, R.
Bubanovic, G.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[4] ERCC1 and RRM1 genes in lung cancer
Carvalho, Lina
Silva, Antonio
Andrade, Claudia
Barroso, Claudia
Farinha, Claudia
Fernandes, Jose Carlos
Landeiro, Raquel
REVISTA PORTUGUESA DE PNEUMOLOGIA, 2009, 15 (04) : 683 - 696
[5] Treatment guided by ERCC1, RRM1, and BRCA1 protein expression in patients with advanced-stage NSCLC
Han, B.
Shen, J.
Gao, Z.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[6] PROGNOSTIC VALUE OF CD133 EXPRESSION AND IT'S COMBINATION WITH EXPRESSIONS OF ERCC1, RRM1 AND BRCA1 IN LUNG CANCER
Su, Chunxia
Xu, Guotong
Zhou, Caicun
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1014 - S1014
[7] PROGNOSTIC VALUE OF CD133 EXPRESSION AND IT'S COMBINATION WITH EXPRESSIONS OF ERCC1, RRM1 AND BRCA1 IN LUNG CANCER
Su, C.
Xu, G.
Zhou, C.
RESPIROLOGY, 2011, 16 : 185 - 185
[8] ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer
Chunxia Su
Songwen Zhou
Ling Zhang
Shengxiang Ren
Jianfang Xu
Jie Zhang
Meijun Lv
Jie Zhang
Caicun Zhou
Medical Oncology, 2011, 28 : 1411 - 1417
[9] Relevance of ERCC1, RRM1 and BRCA1 in surgically treated non-small cell lung cancer patients
Martin Pesta
Ondrej Topolcan
Vlastimil Kulda
Ondrej Fiala
Gabriela Krakorova
Radim Cerny
Milos Pesek
EPMA Journal, 2014, 5 (Suppl 1):
[10] ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer
Su, Chunxia
Zhou, Songwen
Zhang, Ling
Ren, Shengxiang
Xu, Jianfang
Zhang, Jie
Lv, Meijun
Zhang, Jie
Zhou, Caicun
MEDICAL ONCOLOGY, 2011, 28 (04) : 1411 - 1417

← 1 2 3 4 5 →